Objective: We describe q-sequence deconvolution (QSD), a new data acquisition/analysis method for evoked-responses that solves the problem of waveform distortion at high stimulus repetitionrates, due to response overlap. QSD can increase the sensitivity of clinically useful evoked-responses because it is well known that high stimulus repetition-rates are better for detecting pathophysiology.Methods: QSD is applicable to a variety of experimental conditions. Because some QSD-parameters must be chosen by the experimenter, the underlying principles and assumptions of the method are described in detail. The theoretical and mathematical bases of the QSD method are also described, including some equivalent computational formulations.Results: QSD was applied to recordings of the human auditory brainstem response (ABR) at stimulus repetition-rates that overlapped the responses. The transient ABR was recovered at all rates tested (highest 160/s), and showed systematic changes with stimulus repetition-rate within a single subject.
Conclusions: QSD offers a new method of recovering brain evoked-response activity having a duration longer than the time between stimuli.Significance: The use of this new technique for analysis of evoked responses will permit examination of brain activation patterns across a broad range of stimulus repetition-rates, some never before studied. Such studies will improve the sensitivity of evoked-responses for the detection of brain pathophysiology. New measures of brain activity may be discovered using QSD. The method also permits the recovery of the transient brain waveforms that overlap to form 'steady-state' waveforms. An additional benefit of the QSD method is that repetition-rate can be isolated as a variable, independent of other stimulus characteristics, even if the response is a nonlinear function of rate.
Contour curvature (CC) is a vital cue for the analysis of both form and motion. Using functional magnetic resonance imaging, we localized the neural correlates of CC for the processing and perception of rotational motion. We found that the blood oxygen level-dependent signal in retinotopic area V3A and possibly also lateral occipital cortex (LOC) varied parametrically with the degree of CC. Control experiments ruled out the possibility that these modulations resulted from either changes in the area of the stimuli, the velocity with which contour elements were actually translating, or perceived angular velocity. We conclude that neurons within V3A and perhaps also LOC process continuously moving CC as a trackable feature. These data are consistent with the hypothesis that V3A contains neural populations that process trackable form features such as CC, not to solve the "ventral problem" of determining object shape but in order to solve the "dorsal problem" of what is going where.
A new motion illusion, "illusory rebound motion" (IRM), is described. IRM is qualitatively similar to illusory line motion (ILM). ILM occurs when a bar is presented shortly after an initial stimulus such that the bar appears to move continuously away from the initial stimulus. IRM occurs when a second bar of a different color is presented at the same location as the first bar within a certain delay after ILM, making this second bar appear to move in the opposite direction relative to the preceding direction of ILM. Three plausible accounts of IRM are considered: a shifting attentional gradient model, a motion aftereffect (MAE) model, and a heuristic model. Results imply that IRM arises because of a heuristic about how objects move in the environment: In the absence of countervailing evidence, motion trajectories are assumed to continue away from the location where an object was last seen to move.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.